+987.9%
MRNA vs FND
-10.3%
+998.2%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | FND | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +10.9% | +2.2% | +7.7% |
| 7D | +20.6% | +12.3% | +8.3% | +14.0% |
| 30D | +27.1% | +14.7% | +12.4% | +17.8% |
| 3M | +353.4% | -12.0% | +365.4% | +382.7% |
| 6M | +446.3% | +10.8% | +435.5% | +433.3% |
| YTD | +776.2% | -12.3% | +788.4% | +810.9% |
| 1Y | +987.9% | -13.4% | +1,001.3% | +1,027.8% |
| All | +987.9% | -10.3% | +998.2% | +1,027.8% |
Cumulative growth
Daily Returns
Daily percentage return beside FND.
Daily Out/Under-Performance
Portfolio return minus FND return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FND return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded FND wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling